March Biosciences has forged a strategic alliance with CTMC, a joint venture between Resilience + MD Anderson Cancer Center. The partnership is focused on the development of March Biosciences' lead asset, MB-105, and advanced cellular therapy currently in clinical studies.| March Biosciences - A clinical-stage cell-therapy company targeting challengi...
How do you bring promising cancer research to the masses? TMC Innovation's Accelerator for Cancer Therapeutics was established with that question in mind.| InnovationMap
For the second time this year, Houston life science leaders and startup founders gathered to discuss the future of health care in Houston.| InnovationMap
It's almost unreal what can be done with therapeutics today, especially in the specialty of cell therapy.| InnovationMap
When cancer originates in a patient, their body fights as hard as it can against the disease, but sometimes, the cancer wins the battle. However, one Houston cell therapy startup is working on an artillery of therapeutics to help arm patients' bodies to win the war.| InnovationMap